BioNTech SE
XETRA:22UA
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
B
|
BioNTech SE
XETRA:22UA
|
DE |
|
N
|
Neuraxis Inc
AMEX:NRXS
|
US |
Wall St Price Targets
22UA Price Targets Summary
BioNTech SE
According to Wall Street analysts, the average 1-year price target for 22UA is 115.24 EUR with a low forecast of 75.1 EUR and a high forecast of 166.25 EUR.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is 22UA's stock price target?
Price Target
115.24
EUR
According to Wall Street analysts, the average 1-year price target for 22UA is 115.24 EUR with a low forecast of 75.1 EUR and a high forecast of 166.25 EUR.
What is the Revenue forecast for BioNTech SE?
Projected CAGR
-2%
Over the last 7 years, the compound annual growth rate for Revenue has been 56%. The projected CAGR for the next 3 years is -2%.
What is the Gross Profit forecast for BioNTech SE?
Projected CAGR
-11%
Over the last 7 years, the compound annual growth rate for Gross Profit has been 55%. The projected CAGR for the next 3 years is -11%.
